| Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on-and off-rates against non-Hodgkin … Y Zhang, RP Patel, KH Kim, H Cho, JC Jo, SH Jeong, SY Oh, YS Choi, ... Molecular cancer 22 (1), 200, 2023 | 15 | 2023 |
| Apoptosis: A Janus bifrons in T-cell immunotherapy YG Lee, N Yang, I Chun, P Porazzi, A Carturan, L Paruzzo, CT Sauter, ... Journal for Immunotherapy of Cancer 11 (4), e005967, 2023 | 12 | 2023 |
| CD5 deletion enhances the antitumor activity of adoptive T cell therapies RP Patel, G Ghilardi, Y Zhang, YH Chiang, W Xie, P Guruprasad, KH Kim, ... Science Immunology 9 (97), eadn6509, 2024 | 9 | 2024 |
| The BTLA–HVEM axis restricts CAR T cell efficacy in cancer P Guruprasad, A Carturan, Y Zhang, JH Cho, KG Kumashie, RP Patel, ... Nature immunology 25 (6), 1020-1032, 2024 | 8 | 2024 |
| Inhibition of EZH2 improves CART19 immunotherapy by reprogramming lymphoma tumor cells and enhancing T-cell functionality P Porazzi, Y Isshiki, G Ghilardi, S Nason, Z Yang, A Carturan, L Chen, ... Blood 142, 1018, 2023 | 2 | 2023 |
| Systemic inflammatory and autoimmune diseases associated to myelodysplastic syndromes have no impact on outcome A Carturan, E Morsia, M Pianelli, EB Marinelli, D Lame, A Olivieri, ... Haematologica 106 (Suppl 3), 81, 2021 | 2 | 2021 |
| Modulation of the Btla-HVEM Axis to Enhance CAR T Cell Immunotherapy Against Cancer P Guruprasad, A Carturan, Y Zhang, KG Kumashie, IJ Cohen, G Ghilardi, ... Blood 142 (Supplement 1), 768-768, 2023 | 1 | 2023 |
| Transfusion dependence is a risk factor for severe infections in myelodysplastic syndromes. M Pianelli, E Morsia, D Lame, A Carturan, A Olivieri, A Poloni Leukemia Research 124, 107000-107000, 2022 | 1 | 2022 |
| EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models P Porazzi, S Nason, Z Yang, A Carturan, G Ghilardi, P Guruprasad, ... Cancer Cell, 2025 | | 2025 |
| Advances in the understanding and therapeutic manipulation of cancer immune responsiveness: a Society for Immunotherapy of Cancer (SITC) review A Cesano, R Augustin, L Barrea, D Bedognetti, TC Bruno, A Carturan, ... Journal for immunotherapy of cancer 13 (1), e008876, 2025 | | 2025 |
| Shaping the Future of Myeloproliferative Neoplasm Therapy: Immune-Based Strategies and Targeted Innovations A Carturan, S Morè, A Poloni, S Rupoli, E Morsia Cancers 16 (23), 4113, 2024 | | 2024 |
| Overcoming the Lack of CD2: CD58 Costimulation in Chimeric Antigen Receptor T-Cell Immunotherapies A Carturan, MG Angelos, R Pajarillo, J Rodriguez, J Harris, Y Zhang, ... Blood 144, 504, 2024 | | 2024 |
| Ketogenic Diet Enhances CAR T Cell Antitumor Function Via β-Hydroxybutyrate S Liu, P Guruprasad, K Han, L Paruzzo, A Shestov, A Kelly, KR Amses, ... Blood 144, 4, 2024 | | 2024 |
| Access and Outcomes of Minority Health Populations Receiving Commercial Anti-BCMA CART Therapy for Multiple Myeloma L Paruzzo, K Eshaghi, G Ghilardi, A Doucette, A Waxman, AD Cohen, ... Blood 144 (Supplement 1), 3779-3779, 2024 | | 2024 |
| EZH1/2 Inhibition Improves the Anti-Tumor Efficacy of CAR and TCR T-Cell Based Therapies Against Multiple Liquid and Solid Tumors S Nason, Z Yang, G Ghilardi, L Paruzzo, A Carturan, E Fardella, ... Blood 144, 4792, 2024 | | 2024 |
| Streamlined measurement of chimeric antigen receptor T-cell concentration, size, viability and two-color phenotyping during manufacturing R Pajarillo, L Paruzzo, A Carturan, O Ugwuanyi, G White, P Guruprasad, ... Cytotherapy 26 (5), 506-511, 2024 | | 2024 |
| A First-in-Human Phase I Study of AT101, a Novel Anti-CD19 Chimeric Antigen Receptor T Cell Product Targeting a Membrane-Proximal Domain of CD19 in Adults with Relapsed or … Y Zhang, RP Patel, KH Kim, H Cho, JC Cho, SH Jeong, SY Oh, YS Choi, ... Blood 142 (Supplement 1), 2096-2096, 2023 | | 2023 |
| Immunotherapy: THE BTLA-HVEM AXIS IS A CRUCIAL IMMUNE CHECKPOINT OF T CELL IMMUNOTHERAPIES FOR CANCER P Guruprasad, A Carturan, Y Zhang, G Ghilardi, K Kumashie, K Kim, ... Cytotherapy 25 (6), S226-S227, 2023 | | 2023 |
| A rare case of aCML associated with CNS involvement and with aggressive clinical course D Lame, M Pianelli, E Morsia, A Carturan, G Goteri, S Mancini, A Olivieri, ... Leukemia Research Reports 19, 100361, 2023 | | 2023 |
| Epidemiology and Risk Factors for Infections in Myelodysplastic Syndromes A Poloni, A Carturan, M Pianelli, E Morsia, D Lame, A Olivieri Blood 138 (Supplement 1), 4667-4667, 2021 | | 2021 |